News & Analysis as of

Pharmaceutical Industry › Food and Drug Administration (FDA) › Kim Kardashian

Mintz - Health Care Viewpoints

FDA Cites Drug Company for Kim Kardashian Endorsement

Mintz - Health Care Viewpoints on

This week might have been the first time that an FDA regulatory issue hit the headlines on TMZ and other “celebrity watcher” websites. In an August 7 Warning Letter sent to the drug company Duchesnay, Inc., FDA complains...more

Kelley Drye & Warren LLP

FDA Recalls Kim Kardashian’s Post

Kelley Drye & Warren LLP on

Last month, Kim Kardashian praised Diclegis, a drug for morning sickness, on her social media accounts. Since Kim doesn’t follow us on social media, we don’t always keep tabs on her. But when her posts raise regulatory...more

Faegre Drinker Biddle & Reath LLP

OMG: Kim Kardashian Prompts FDA Warning Letter

Faegre Drinker Biddle & Reath LLP on

Kim Kardashian recently trumpeted the beneficial effects of Diclegis, a pill indicated for the treatment of nausea and vomiting of pregnancy for certain women, to her over 42 million Instagram followers. One such Kardashian...more

3 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide